Importer of Controlled Substances Registration, 23581-23582 [2019-10669]

Download as PDF Federal Register / Vol. 84, No. 99 / Wednesday, May 22, 2019 / Notices 87104. Or email comments to: JOMcomments@bie.edu. jbell on DSK3GLQ082PROD with NOTICES FOR FURTHER INFORMATION CONTACT: Angela Barnett, Program Specialist, Bureau of Indian Education; telephone (405) 605–6051 ext. 302; email ANGELA.BARNETT1@bie.edu. SUPPLEMENTARY INFORMATION: The JOM Act of 1934 was enacted to subsidize education, medical services, and other social services provided to Indians living within the borders of states and territories. Today, JOM funding is used to support programs designed to meet the specialized and unique educational and cultural needs of eligible Indian students, including programs that supplement existing school programming operational supports. The JOM Modernization Act, Public Law 115–404, enacted December 31, 2018, directs the Secretary of the Interior (Secretary) to conduct an accurate and comprehensive student count for the purposes of calculating formula allocations for programs under the JOM Act and for other purposes. The JOM Modernization Act also requires the Secretary to make an initial determination of the number of eligible Indian students served, or potentially served, by each eligible entity. In accordance with the JOM Modernization Act, the BIE will use the most applicable and accurate data (from the fiscal year preceding the fiscal year for which the initial determination is to be made) from one of the following sources: 1. Bureau of the Census; 2. National Center for Education Statistics; or 3. Office of Indian Education of the Department of Education. The BIE would like feedback on which of these three sources can provide the most accurate data for use in the preliminary report. To obtain this feedback, BIE is announcing Tribal consultation sessions and the opportunity for eligible entities and interested parties to provide input. Eligible entities include existing JOM contractors and potential JOM contractors, including States, public school districts, tribal organizations, Indian corporations, and previously private schools. Interested parties include, but are not limited to, JOM Indian Education Committee members, Tribal organizations, employees of public schools serving American Indian students, urban Indian communities, VerDate Sep<11>2014 17:29 May 21, 2019 Jkt 247001 Indian school boards, parents, and student organizations. BIE is also interested in determining the interest of Tribes, State and local educational agencies, and Alaska Native organizations of entering into JOM contracts. BIE will conduct a telephonic consultation session and will accept both oral and written comments. The first hour of the session is reserved for Tribal leaders and their representatives to provide input. The rest of the time is open to eligible parties and any other interested parties who would like to provide input, as follows: June 21, 2019. 1 p.m.–3 p.m. MDT. Please visit & join the meeting space from your computer, tablet, or smartphone. https://www.gotomeet.me/ valerietodacheene/jom-consultation-mlesky. Call-in number: (312) 757–3121. Passcode: 843–649–541. You can find additional information at the BIE JOM web page at: https:// www.bie.edu/JOM/. The BIE strongly recommends that anyone planning to attend a consultation session first review the preliminary data located on BIE’s web page, to best engage in meaningful dialogue. At the conclusion of the consultations, BIE will publish the preliminary report and announce its availability in the Federal Register. Following publication of the preliminary report, BIE will again seek feedback for consideration in preparing the final report. Dated: May 7, 2019. Tara Sweeney, Assistant Secretary—Indian Affairs. [FR Doc. 2019–10718 Filed 5–21–19; 8:45 am] BILLING CODE 4337–15–P 23581 Notice of information collection; withdrawal. ACTION: The National Park Service is withdrawing a notice requesting comments published in the May 14, 2019 issue of the Federal Register entitled ‘‘National Park Service President’s Park National Christmas Tree Music Program Application’’. DATES: As of May 22, 2019 the document published at 84 FR 21354 on May 14, 2019, is withdrawn. FOR FURTHER INFORMATION CONTACT: Phadrea Ponds, Acting NPS Information Collection Clearance Officer, 1201 Oakridge Drive, Fort Collins, CO 80525; at 970–267–7231. SUPPLEMENTARY INFORMATION: The National Park Service wishes to inform the public it is withdrawing a 60-day public notice in the Federal Register titled, ‘‘National Park Service President’s Park National Christmas Tree Music Program Application’’ (84 FR 21354) published on Wednesday, May 14, 2019. This notice was published in error and is being withdrawn immediately for public comment. SUMMARY: Phadrea Ponds, Acting Information Collection Clearance Officer, National Park Service. [FR Doc. 2019–10697 Filed 5–21–19; 8:45 am] BILLING CODE 4312–52–P DEPARTMENT OF JUSTICE Drug Enforcement Administration [Docket No. DEA–392] Importer of Controlled Substances Registration ACTION: Notice of registration. The registrants listed below have applied for and been granted registration by the Drug Enforcement Administration (DEA) as importers of schedule I and schedule II controlled substances. SUMMARY: DEPARTMENT OF THE INTERIOR National Park Service [NPS–NCR–WHHO–SSB–NPS0027381; PPNCWHHOP0, PPMVSIE1Z.I00000 (199); OMB Control Number 1024–0277] Agency Information Collection Activities; National Park Service President’s Park National Christmas Tree Music Program Application; Withdrawal AGENCY: PO 00000 National Park Service, Interior. Frm 00060 Fmt 4703 Sfmt 4703 The companies listed below applied to be registered as importers of various basic classes of controlled substances. Information on previously published notices is listed in the table below. No comments or objections were submitted and no requests for a hearing were submitted for these notices. SUPPLEMENTARY INFORMATION: E:\FR\FM\22MYN1.SGM 22MYN1 23582 Federal Register / Vol. 84, No. 99 / Wednesday, May 22, 2019 / Notices Company FR docket Meridian Medical Technologies ....................................................................................................... Organic Standards Solutions International, LLC ............................................................................. SpecGx LLC .................................................................................................................................... 84 FR 7129 ............... 84 FR 13958 ............. 84 FR 13954 ............. The DEA has considered the factors in 21 U.S.C. 823, 952(a) and 958(a) and determined that the registration of the listed registrants to import the applicable basic classes of schedule I and II controlled substances is consistent with the public interest and with United States obligations under international treaties, conventions, or protocols in effect on May 1, 1971. The DEA investigated each of the company’s maintenance of effective controls against diversion by inspecting and testing each company’s physical security systems, verifying each company’s compliance with state and local laws, and reviewing each company’s background and history. Therefore, pursuant to 21 U.S.C. 952(a) and 958(a), and in accordance with 21 CFR 1301.34, the DEA has granted a registration as an importer for schedule I and schedule II controlled substances to the above listed companies. Drive, Springfield, Virginia 22152; and (2) Drug Enforcement Administration, Attn: DEA Federal Register Representative/DPW, 8701 Morrissette Drive, Springfield, Virginia 22152. SUPPLEMENTARY INFORMATION: The Attorney General has delegated his authority under the Controlled Substances Act to the Administrator of the Drug Enforcement Administration (DEA), 28 CFR 0.100(b). Authority to exercise all necessary functions with respect to the promulgation and implementation of 21 CFR part 1301, incident to the registration of manufacturers, distributors, dispensers, importers, and exporters of controlled substances (other than final orders in connection with suspension, denial, or revocation of registration) has been redelegated to the Assistant Administrator of the DEA Diversion Control Division (‘‘Assistant Administrator’’) pursuant to section 7 of 28 CFR part 0, appendix to subpart R. In accordance with 21 CFR 1301.34(a), this is notice that on March 8, 2019, United States Pharmacopeial, 12601 Twinbrook Parkway, Rockville, Maryland 20852–1717 applied to be registered as an importer of the following basic classes of controlled substances: Dated: May 7, 2019. John J. Martin, Assistant Administrator. [FR Doc. 2019–10669 Filed 5–21–19; 8:45 am] BILLING CODE 4410–09–P DEPARTMENT OF JUSTICE Drug Enforcement Administration [Docket No. DEA–392] Importer of Controlled Substances Application: United States Pharmacopeial Convention ACTION: Notice of application. Registered bulk manufacturers of the affected basic classes, and applicants therefore, may file written comments on or objections to the issuance of the proposed registration on or before June 21, 2019. Such persons may also file a written request for a hearing on the application on or before June 21, 2019. ADDRESSES: Written comments should be sent to: Drug Enforcement Administration, Attention: DEA Federal Register Representative/DPW, 8701 Morrissette Drive, Springfield, Virginia 22152. All requests for a hearing must be sent to: Drug Enforcement Administration, Attn: Administrator, 8701 Morrissette Drive, Springfield, Virginia 22152. All request for a hearing should also be sent to: (1) Drug Enforcement Administration, Attn: Hearing Clerk/OALJ, 8701 Morrissette DATES: jbell on DSK3GLQ082PROD with NOTICES Controlled substance 17:29 May 21, 2019 Jkt 247001 PO 00000 Frm 00061 Fmt 4703 March 1, 2019. April 8, 2019. April 8, 2019. Drug code Methamphetamine ........................................................................................................................................................... Cathinone ........................................................................................................................................................................ Phenmetrazine ................................................................................................................................................................. Methylphenidate .............................................................................................................................................................. Amobarbital ...................................................................................................................................................................... Pentobarbital .................................................................................................................................................................... Secobarbital ..................................................................................................................................................................... Glutethimide ..................................................................................................................................................................... Methaqualone .................................................................................................................................................................. Lysergic acid diethylamide .............................................................................................................................................. 4-Methyl-2,5-dimethoxyamphetamine ............................................................................................................................. 3,4-Methylenedioxyamphetamine .................................................................................................................................... 4-Methoxyamphetamine .................................................................................................................................................. Phencyclidine ................................................................................................................................................................... 4-Anilino-N-phenethyl-4-piperidine (ANPP) ..................................................................................................................... Phenylacetone ................................................................................................................................................................. Alphaprodine .................................................................................................................................................................... Anileridine ........................................................................................................................................................................ Cocaine ............................................................................................................................................................................ Codeine-N-oxide .............................................................................................................................................................. Dihydrocodeine ................................................................................................................................................................ Difenoxin .......................................................................................................................................................................... Diphenoxylate .................................................................................................................................................................. Heroin .............................................................................................................................................................................. Levomethorphan .............................................................................................................................................................. Levorphanol ..................................................................................................................................................................... Meperidine ....................................................................................................................................................................... Dextropropoxyphene, bulk (non-dosage forms) .............................................................................................................. VerDate Sep<11>2014 Published Sfmt 4703 E:\FR\FM\22MYN1.SGM 22MYN1 1105 1235 1631 1724 2125 2270 2315 2550 2565 7315 7395 7400 7411 7471 8333 8501 9010 9020 9041 9053 9120 9168 9170 9200 9210 9220 9230 9273 Schedule II I II II II II II II I I I I I II II II II II II I II I II I II II II II

Agencies

[Federal Register Volume 84, Number 99 (Wednesday, May 22, 2019)]
[Notices]
[Pages 23581-23582]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-10669]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

[Docket No. DEA-392]


Importer of Controlled Substances Registration

ACTION: Notice of registration.

-----------------------------------------------------------------------

SUMMARY: The registrants listed below have applied for and been granted 
registration by the Drug Enforcement Administration (DEA) as importers 
of schedule I and schedule II controlled substances.

SUPPLEMENTARY INFORMATION: The companies listed below applied to be 
registered as importers of various basic classes of controlled 
substances. Information on previously published notices is listed in 
the table below. No comments or objections were submitted and no 
requests for a hearing were submitted for these notices.

[[Page 23582]]



----------------------------------------------------------------------------------------------------------------
                    Company                                FR docket                        Published
----------------------------------------------------------------------------------------------------------------
Meridian Medical Technologies.................  84 FR 7129.....................  March 1, 2019.
Organic Standards Solutions International, LLC  84 FR 13958....................  April 8, 2019.
SpecGx LLC....................................  84 FR 13954....................  April 8, 2019.
----------------------------------------------------------------------------------------------------------------

    The DEA has considered the factors in 21 U.S.C. 823, 952(a) and 
958(a) and determined that the registration of the listed registrants 
to import the applicable basic classes of schedule I and II controlled 
substances is consistent with the public interest and with United 
States obligations under international treaties, conventions, or 
protocols in effect on May 1, 1971. The DEA investigated each of the 
company's maintenance of effective controls against diversion by 
inspecting and testing each company's physical security systems, 
verifying each company's compliance with state and local laws, and 
reviewing each company's background and history.
    Therefore, pursuant to 21 U.S.C. 952(a) and 958(a), and in 
accordance with 21 CFR 1301.34, the DEA has granted a registration as 
an importer for schedule I and schedule II controlled substances to the 
above listed companies.

    Dated: May 7, 2019.
John J. Martin,
Assistant Administrator.
[FR Doc. 2019-10669 Filed 5-21-19; 8:45 am]
 BILLING CODE 4410-09-P